Article
30 Jul 2025
Patented Drug Pricing: The PMPRB Releases New Price-Review Guidelines
AUTHORS CONTENT
Article
03 Mar 2025
The New Due Care Roadmap: How To Avoid Deemed Expiry Or Abandonment Of Your Patent And Design Rights
Article
10 Feb 2025
The Patent Act Prevails – The Court Of Appeal Of Alberta Clarifies The Law On Limitation Periods For Patent Infringement Claims
Article
18 Jul 2024
Where Does Infringement Arise? Untangling The Knot Of Patent Infringement Limitation Periods
Article
27 Feb 2024
PMPRB "What We Learned Report" Released
Article
30 Jan 2024
Canadian Patent Law In Review 2023: Notable Cases And Trends For 2024
Article
22 Nov 2023
PMPRB Announces Scoping Paper For The Consultation On New Guidelines And Opens Stakeholder Registration For Policy Roundtables
Article
08 Nov 2023
PMPRB Announces Next Steps In Guidelines Consultation Process
Article
16 Oct 2023
Patented Medicine Prices Review Board Adopts Amended Interim Guidance On Pricing Of New Medicines
Article
13 Jul 2023
FCA Confirms The Importance Of Counsel's Role In Maintaining The Independence Of Experts
Article
22 May 2023
Bill C-47 Proposes To Amend Patent Act To Implement Cusma
Article
17 May 2023
FCA Confirms Test For Inducing Patent Infringement
Article
11 Jan 2023
Key Canadian Patent Law Decisions From 2022 And Some Predictions For 2023
Article
23 Dec 2022
Changes To List Of Comparator Countries Used To Assess Pricing Of Patented Medicines Affirmed On Appeal
Article
24 Nov 2022
Springing Into Action: Supreme Court Of Canada Clarifies Accounting Of Profits Remedy In Patent Infringement Cases
Article
15 Jun 2022
Canada's 2030 Emission Reduction Plan: Opportunities For Intellectual Property Innovators
Article
02 Jun 2022
ElevateIP: Government Of Canada Releases Call For Proposals To Support Development Of IP
Article
28 Mar 2022
Recent Developments In Intellectual Property: New Initiatives For IP Strategy And Management